R

Revolution Medicines
D

RVMD

59.010
USD
-0.42
(-0.71%)
Market Closed
Volume
83,502
EPS
0
Div Yield
0
P/E
-16
Market Cap
9,856,968,026
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    4.380
    (2.36%)
    189.700 USD
    AMGN
    2.78
    (0.84%)
    335.22 USD
    BMY
    0.620
    (1.30%)
    48.180 USD
    GSK
    0.865
    (2.23%)
    39.650 USD
    LLY
    28.47
    (3.54%)
    832.74 USD
    MRK
    0.680
    (0.60%)
    113.800 USD
    NVO
    -0.070
    (-0.05%)
    132.560 USD
    NVS
    0.650
    (0.58%)
    112.100 USD
    PFE
    0.115
    (0.38%)
    30.650 USD
    SNY
    -0.090
    (-0.17%)
    51.700 USD
    More
News

Title: Revolution Medicines

Sector: Healthcare
Industry: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.